Dr. Sarah Jenkins is a board-certified endocrinologist specializing in Type 2 diabetes management, metabolic syndrome, and cardiovascular disease prevention. She received her Medical Degree (MD) from Johns Hopkins University School of Medicine and completed her Endocrinology, Diabetes, and Metabolism Fellowship at the Mayo Clinic.

Throughout her clinical career, Dr. Jenkins has championed patient-centered care that combines evidence-based lifestyle modification with modern pharmacotherapy. Her clinical research has appeared in peer-reviewed journals focusing on insulin sensitivity protocols and postprandial glucose regulation.

At GlucoHarbor, Dr. Jenkins leads our medical review panel. She reviews high-complexity clinical articles, dosage guides, and diagnostic thresholds to guarantee alignment with standards established by the American Diabetes Association (ADA) and the Endocrine Society.